Bryant D. Lim - 04 Feb 2026 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
CLO, CFO, Corp Sec.
Signature
/s/ Bryant D. Lim
Issuer symbol
PRLD
Transactions as of
04 Feb 2026
Net transactions value
$0
Form type
4
Filing time
05 Feb 2026, 16:11:32 UTC
Previous filing
05 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lim Bryant David CLO, CFO, Corp Sec. C/O PRELUDE THERAPEUTICS INCORPORATED, 175 INNOVATION BOULEVARD, WILMINGTON /s/ Bryant D. Lim 05 Feb 2026 0001752888

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Employee Stock Option (right to buy) Award $0 +275,000 $0.000000 275,000 04 Feb 2026 Common Stock 275,000 $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on Feb 4, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.